# Safety and Efficacy Study of Orally Administered DS102 in Healthy Subjects

> **NCT02673593** · PHASE1 · COMPLETED · sponsor: **DS Biopharma** · enrollment: 57 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** DS102
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02673593
- **Lead sponsor:** DS Biopharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2016-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02673593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02673593, "Safety and Efficacy Study of Orally Administered DS102 in Healthy Subjects". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT02673593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*